XML 56 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders Equity and StockBased Compensation (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Mar. 14, 2025
Mar. 12, 2025
Dec. 04, 2024
Mar. 24, 2025
Feb. 27, 2025
Feb. 26, 2025
Nov. 22, 2024
Aug. 19, 2024
Mar. 29, 2024
Feb. 27, 2024
Nov. 20, 2023
May 28, 2019
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Options outstanding, Granted                         10,448 58,309  
Exercise price lower range limit                         $ 5.74 $ 1.03  
Total fair value                         $ 60,000 $ 60,000  
Stock-based compensation expense                         $ 1,355,181 $ 456,904  
Outstanding restricted stock awards                         743,702 557,688 781,864
Preferred Stock, par value                         $ 0.001   $ 0.001
Common Stock, Shares Issued                         21,557,343   21,557,343
Stock options vested                         409,789   445,275
Proceeds from stock option exercise                         $ 220,697 $ 0  
Unrecognized compensation cost related to option awards                         $ 35,388 $ 35,384  
Unrecognized compensation cost related to option awards vesting period                         1 year 10 months 24 days 1 year 10 months 24 days  
Common Stock, Shares Outstanding                         21,557,343   18,783,912
Common Stock, Shares Authorized                         25,000,000   25,000,000
ATM Agreement amendment, description                       Under this amended agreement, the Company pays Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement. The offering of common stock pursuant to this agreement can be terminated with 10 days written notice by either party      
Consulting expense                         $ 5,145,923 $ 3,181,568  
Weighted average grant date fair value                         $ 9.42 $ 2.62  
Fair value of the Company's common stock per share                         7.46 $ 2.95  
Fair value of the Company's common stock per share                         $ 17.29   $ 16.24
Outstanding shares of common stock and ommon stock equivalents                         21,986,797   19,248,852
Stock options outstanding                         429,454 555,582 464,940
Offering price, ATM             $ 45,000,000.0                
Description related to ATM offerings                 The Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) on March 29, 2024, registering the sale of up to $75.0 million of the Company’s securities that was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement, which was further supplemented on July 19, 2024 and August 9, 2024 (collectively, the “First Prospectus Supplement”), pursuant to which the Company may offer and sell shares of common stock having an aggregate offering price of up to $12.6 million from time to time through the ATM. The Company exhausted all sales under the First Prospectus Supplement            
Series X Preferred Stock [Member]                              
Redemption Price of Preferred Stock         $ 100                    
Preferred Stock, par value         $ 0.001                    
Cash         $ 100                    
Description of subscription and investment representation agreement         (1) share of the Company’s Series X Preferred Stock, par value $0.001 per share (the “Series X Preferred Stock”), to the Purchaser for $100 in cash. The sale closed on February 27, 2025 and the $100 was fully paid-up and recorded under current liabilities. The Company will redeem the Series X Preferred Stock for $100 cash after the Company’s annual 2025 shareholder meeting (the “Annual Meeting”).                    
Preferred stock voting rights shares         25,000,000                    
Prepaid Expenses And Other Current Assets [Member]                              
Unrecognized compensation cost related to option awards                         $ 69,000    
Unrecognized compensation cost related to option awards vesting period                         4 months 24 days    
Common Share Issuances [Member]                              
Stock-based compensation expense                         $ 15,000 $ 15,000  
Shares of common stock issued                         3,171 3,750  
Weighted average grant date fair value                         $ 4.73 $ 4.00  
2020 Equity Incentive Plan [Member]                              
Common stock available for future issuance                         1,009,389    
Total number of common stock available for future issuance                         2,500,000    
Description of Equity incentive plan           the Company’s Board of Directors approved an increase of 2,500,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 2,500,000 to 5,000,000       the Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares          
2025 Transactions [Member]                              
Total fair value                         $ 300,000    
Stock-based compensation expense                         $ 500,000    
Shares, vested                         70,710    
Unrecognized compensation cost related to option awards                         $ 200,000    
RSAs Modification and Net Share Settlements for Payments of Withholding Taxes, Description 10,907 RSAs vested to the former employee based on his service to the Company. To satisfy approximately $36,000 in payroll withholding taxes, the Company withheld 3,863 shares, resulting in the issuance of 7,044 net shares to the former employee     approximately $0.2 million in payroll withholding taxes associated with the accelerated RSAs vesting, the Company withheld 21,285 shares, resulting in the issuance of 49,425 net shares to the former employee                      
RSA Summary 2025 and 2024 [Member]                              
Stock-based compensation expense                         $ 1,300,000 $ 400,000  
Common Stock, Shares Issued                         743,702 781,864  
Common Stock, Shares Outstanding                         743,702 781,864  
Fair value of the RSAs vested                         $ 500,000    
Available for sale Securities [Member]                              
Proceeds from sale of common stock, shares                         2,605,619 427,300  
Net proceeds from stock issuance under ATM                         $ 20,200,000 $ 1,200,000  
Stock issuence cost                         700,000 200,000  
Options [Member]                              
Proceeds from stock option exercise                         $ 200,000    
Proceeds from Stock options, shares                         45,934    
Board of Directors Chairman [Member]                              
Common shares issuances equity grant value     $ 500,000         $ 180,000     $ 240,000        
Common shares equity grant price per shares     $ 5.82               $ 3.97        
Number of shares granted     85,915         71,713     60,456        
Compensation cost recognized               $ 180,000              
Consulting expense                         $ 45,000 $ 0  
Common stock, valued grant date price per share               $ 2.51              
Board of Directors Chairman [Member] | Restricted Stock Units R S A [Member]                              
Shares, Granted   14,485                     57,940    
Stock-based compensation expense                         $ 100,000    
Weighted average fair value grant date, granted                         $ 8.63    
Equity grant approved by board of directors   $ 500,000                          
Stock options vested                         700,000   0
Unrecognized compensation cost related to option awards                         $ 3,500,000    
Unrecognized compensation cost related to option awards vesting period                         2 years 1 month 20 days    
Fair value of the Company's common stock per share                         $ 7.46 $ 2.95  
Board of Directors [Member] | Maximum                              
Common Stock, Shares Authorized           100,000,000                  
Board of Directors [Member] | Minimum                              
Common Stock, Shares Authorized           25,000,000